CYRS-101

N/A

Report date: 2025/06/11 11:23:27
NME

Base Information

Drug NameCYRS-101
Drug Alias NameGLP-1 receptor agonist (Hyundai Pharma/Cyrus Therapeutics)GLP-1 receptor agonist (Cyrus Therapeutics)HDNO-1765CYRS-101
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHyundai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCyrus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A